Profile data is unavailable for this security.
About the company
Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.
- Revenue in USD (TTM)0.00
- Net income in USD-25.85m
- Incorporated2010
- Employees11.00
- LocationGlucoTrack Inc301 Rt 17 North, Suite 800RUTHERFORD 07070United StatesUSA
- Phone+1 (9728) 675-7878
- Fax+1 (302) 655-5049
- Websitehttps://glucotrack.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aditxt Inc | 5.95k | -42.24m | 1.10m | 26.00 | -- | -- | -- | 184.23 | -13,234.74 | -13,234.74 | 0.3444 | -151.86 | 0.0003 | 1.54 | 0.0304 | 228.85 | -207.03 | -148.78 | -- | -279.11 | -1,134.96 | -- | -724,419.70 | -8,283.15 | 0.02 | -12.48 | -- | -- | -79.23 | -- | -23.40 | -- | -- | -- |
| Halberd Corp | 281.24k | 25.34k | 1.13m | 3.00 | 0.6897 | -- | 44.61 | 4.02 | 0.0023 | 0.0023 | 0.0018 | -0.0002 | 0.1449 | 0.0303 | 2.52 | -- | 1.31 | -- | 4.58 | -- | 50.00 | -- | 9.01 | -- | 0.2661 | 1.35 | 1.02 | -- | 271.52 | -- | -60.11 | -- | -- | -- |
| Pharmagreen Biotech Inc | 3.01k | -226.26k | 1.26m | 0.00 | -- | -- | 2.28 | 418.91 | -0.0003 | -0.0003 | 0.00 | -0.0035 | 0.0286 | 0.2026 | 0.0669 | -- | -214.92 | -709.50 | -- | -- | 44.85 | -- | -7,518.27 | -147,637.60 | 0.0375 | -- | -- | -- | 13.67 | -- | -76.59 | -- | -- | -- |
| Exousia Pro Inc | 0.00 | -854.02k | 1.35m | 0.00 | -- | -- | -- | -- | -0.0642 | -0.0642 | 0.00 | -0.0318 | 0.00 | -- | -- | -- | -1,313,877.00 | -- | -- | -- | -- | -- | -- | -- | -- | -1,816.06 | -- | -- | -- | -- | -248.31 | -- | -- | -- |
| International Stem Cell Corp | 9.39m | -149.00k | 1.40m | 32.00 | -- | -- | 8.70 | 0.1492 | -0.0187 | -0.0187 | 1.17 | 0.0655 | 1.80 | 2.66 | 11.08 | 293,468.80 | -1.13 | -16.11 | -10.84 | -52.88 | 57.86 | 59.53 | -0.6283 | -10.91 | 0.4604 | 0.6258 | 0.8632 | -- | 16.64 | -0.8308 | -59.54 | -- | -19.12 | -- |
| GlucoTrack Inc | 0.00 | -25.85m | 1.50m | 11.00 | -- | 0.5395 | -- | -- | -1,225.32 | -1,225.32 | 0.00 | 3.06 | 0.00 | -- | -- | 0.00 | -567.22 | -147.48 | -- | -192.87 | -- | -- | -- | -- | -- | -3.51 | 0.5422 | -- | -- | -- | -218.40 | -- | 34.73 | -- |
| Virax Biolabs Group Ltd | 2.99k | -5.64m | 1.53m | 19.00 | -- | 0.2545 | -- | 512.94 | -1.25 | -1.25 | 0.0007 | 0.8118 | 0.0004 | 0.5382 | 1.94 | 157.37 | -74.60 | -111.16 | -77.64 | -133.38 | -1,515.05 | -4.50 | -189,095.00 | -7,009.42 | 11.21 | -92.32 | 0.0959 | -- | -95.95 | -42.40 | 9.98 | -- | -- | -- |
| Ensysce Biosciences Inc | 4.49m | -10.97m | 1.54m | 7.00 | -- | 1.15 | -- | 0.3432 | -6.36 | -6.36 | 2.32 | 0.3783 | 0.7144 | -- | 5.02 | 641,138.60 | -174.67 | -48.70 | -270.43 | -62.66 | -- | -- | -244.49 | -501.34 | -- | -457.15 | 0.3071 | -- | 133.58 | -- | 24.83 | -- | -- | -- |
| Carisma Therapeutics Inc | 52.63m | 8.04m | 1.61m | 46.00 | 0.2047 | -- | 0.1687 | 0.0306 | 0.1881 | 0.1881 | 1.26 | -0.0208 | 2.17 | -- | -- | 1,144,174.00 | 33.09 | -26.58 | 51.48 | -30.35 | -- | -- | 15.28 | -169.12 | -- | -- | -- | -- | 31.59 | -- | 30.39 | -- | -1.99 | -- |
| Galera Therapeutics Inc | 0.00 | -8.99m | 1.66m | 3.00 | -- | -- | -- | -- | -0.1302 | -0.1302 | 0.00 | -1.94 | 0.00 | -- | -- | 0.00 | -129.27 | -96.94 | -145.04 | -116.42 | -- | -- | -- | -- | -- | -- | 34.30 | -- | -- | -- | 67.91 | -- | -- | -- |
| Clearmind Medicine Inc | 0.00 | -3.86m | 1.68m | -- | -- | 0.1485 | -- | -- | -30.64 | -30.64 | 0.00 | 7.54 | 0.00 | -- | -- | -- | -57.83 | -128.70 | -178.71 | -360.04 | -- | -- | -- | -- | -- | -- | 0.5987 | -- | -- | -- | 26.60 | -- | -- | -- |
| Agentix Corp | 0.00 | -655.59k | 1.68m | -- | -- | -- | -- | -- | -0.0164 | -0.0164 | 0.00 | -0.0853 | 0.00 | -- | -- | -- | -746.86 | -- | -- | -- | -- | -- | -- | -- | -- | -7.07 | -- | -- | -- | -- | 3.09 | -- | -- | -- |
| Hcw Biologics Inc | 422.03k | -22.21m | 1.76m | 36.00 | -- | -- | -- | 4.16 | -13.96 | -13.96 | 0.2716 | -0.8038 | 0.0162 | -- | 1.24 | 11,723.06 | -46.35 | -53.89 | -- | -66.10 | 20.00 | -- | -2,855.77 | -545.79 | -- | -42.26 | 1.45 | -- | -9.68 | -- | -20.12 | -- | -29.10 | -- |
| Zyversa Therapeutics Inc | 0.00 | -25.70m | 1.83m | 7.00 | -- | -- | -- | -- | -4.46 | -4.46 | 0.00 | -1.45 | 0.00 | -- | -- | 0.00 | -251.13 | -- | -- | -- | -- | -- | -- | -- | -- | -14.60 | -- | -- | -- | -- | 91.14 | -- | -- | -- |
| Bluejay Diagnostics Inc | 0.00 | -20.07m | 1.89m | 7.00 | -- | 0.2963 | -- | -- | -134.42 | -134.42 | 0.00 | 9.01 | 0.00 | -- | -- | 0.00 | -103.46 | -70.71 | -124.04 | -82.92 | -- | -- | -- | -12,694.84 | -- | -- | 0.0028 | -- | -- | -- | -110.38 | -- | 119.51 | -- |
Data as of Feb 17 2026. Currency figures normalised to GlucoTrack Inc's reporting currency: US Dollar USD
12.59%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 28 Jan 2026 | 100.59k | 11.05% |
| Abante Asesores Gesti�n SGIIC SAas of 31 Dec 2025 | 9.06k | 1.00% |
| Alerus Financial, NA (Private Banking)as of 31 Dec 2025 | 4.00k | 0.44% |
| Tower Research Capital LLCas of 30 Sep 2025 | 806.00 | 0.09% |
| UBS Securities LLCas of 31 Dec 2025 | 119.00 | 0.01% |
| Newbridge Financial Services Group, Inc.as of 31 Dec 2025 | 34.00 | 0.00% |
| SBI Securities Co., Ltd.as of 31 Dec 2025 | 9.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 30 Sep 2025 | 7.00 | 0.00% |
| Osaic Advisory Services LLCas of 30 Sep 2025 | 1.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025 | 1.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
